Professional Activities

  • Achaogen, Consultant2008-date
  • Adenium, Scientific Advisory Board, 2013-date
  • Allecra, Scientific Advisory Board, 2013-date
  • Astellas - ad hoc advisory boards2007-date
  • AstraZeneca - ad hoc advisory boards, 2009-date
  • Bioversys, Scientific Advisory Board, 2013-date
  • Curetis - ad hoc advisory boards2012-date
  • Discuva, Scientific Advisory Board2011-date
  • GlaxoSmithKline, Consultant, 2011-date
  • Meiji, Consultant, 2011-date
  • McKinsey - ad hoc advisory boards, 2010-date
  • Roche - ad hoc advisory boards, 2012-date
  • Tetraphase, Scientific Advisory Board, 2009-date
  • Wockhardt, Global Clinical Council, 2013-date

External Activities

  • Hon. Professor, Queen Mary, University of London, 2011-date
  • Visiting Professor, King Saud University, Saudi Arabia, 2011-13
  • Assistant Editor, Journal Antimicrobial Chemotherapy, 1987-90
  • Editorial Board, European Journal of Clinical Microbiology, 1987-91
  • Editor, Journal of Medical Microbiology, 1991-2003
  • Editorial Board, Journal of Antimicrobial Chemotherapy, 1992-95
  • Editorial Board, Antimicrobial Agents and Chemotherapy, 1996-date
  • Editor, International Journal of Antimicrobial Agents, 2002-date
  • Editorial Board, Korean Journal of Internal Medicine, 2011-date
  • British Society for Antimicrobial Chemotherapy (BSAC) Working Party on Surveillance, 1997 - date
  • BSAC, Working Party on Susceptibility Testing, 1997 - date
  • Advisory Board of Asia-Pacific Research Foundation on Infectious Diseases, 1999 -date
  • Organising committee of International Symposium on Antimicrobial Agents and Resistance (ISAAR), 1999-date
  • UK Inter-Departmental Steering Group on ‘Resistance to Antibiotics and Other Antimicrobial Agents’, 1999-2002
  • UK Government Specialist Advisory Committee on Antibiotic Resistance (SACAR), 2000-7
  • Scientific Committee of 4th European Congress of Chemotherapy (Paris, May 2002), 2001-2
  • Scientific Committee of 7th European Congress of Chemotherapy (Florence, October 2005), 2004-5
  • European Commission Working Group on Antibiotic Resistance Genes in genetically modified organisms, 2003-4
  • National Steering on Healthcare Associated Infection, 2004-7
  • Joint British Society for Antimicrobial Chemotherapy/Hospital Infection Society working group on extended-spectrum #03b2-lactamases, 2005-6
  • Advisor to Govt’s Antibiotic Resistance & Healthcare Associated Infection (ARHAI) committee on new resistance development / horizon scanning, 2007-13
  • Member: UK Govt’s Antimicrobial Resistance & Healthcare Associated Infection (ARHAI) Advisory Committee, 2013-date
  • European Committee on Antimicrobial Susceptibility Testing expert rules sub-group, 2008-10
  • British Society for Antimicrobial Susceptibility Testing working party on the Urgent Need for New Antibiotics, 2009-10
  • DEFRA Antibiotic Resistance Co-ordinating group (DARC), 2010-date
  • Joint BSAC / British Infection Association / Infection Prevention Society Working Party on multiresistant pathogens, 2011-date
  • Advisory Board for British Society for Chemotherapy Antibiotic Action Initiative, 2012-date
  • Society for General Microbiology Expert Panel on Sexually Transmitted Infections2012-date
  • CMO’s working group on genomics (Science Group), 2013

ID: 49723